HIF-1α protein can directly activate JFK transcription, which in turn leads to HIF-1α-induced glycolysis and make hypoxic breast cancer cells insensitive to chemo-radiotherapeutic treatment. This evidence concerns the gene FBXO42 and breast cancer.